This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Franz Hammerschmid: Innovator in Allergy Research
Introduction
Franz Hammerschmid is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of allergy research, particularly through his innovative patent related to human IgE binding.
Latest Patents
Hammerschmid holds a patent for the "Elisa screening method for inhibitors of human IgE binding to the high affinity receptor, FcεRIα." This invention is directed towards an assay for high-capacity screening of substances that interfere with the attachment of human IgE to its high-affinity receptor. It also focuses on substances capable of detaching already bound IgE from this receptor. This patent plays a crucial role in the differential analysis between autoimmune disorders and classical allergies.
Career Highlights
Franz Hammerschmid is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to groundbreaking research in the field of immunology and allergy treatment.
Collaborations
Hammerschmid has collaborated with esteemed colleagues such as Georg Stingl and Manfred Auer. These collaborations have further enhanced the impact of his research and innovations in the medical field.
Conclusion
Franz Hammerschmid's contributions to allergy research through his innovative patent demonstrate his commitment to advancing medical science. His work continues to influence the understanding and treatment of allergic conditions.